Clinical Trials Logo

Filter by:
NCT ID: NCT03566134 Not yet recruiting - Overactive Bladder Clinical Trials

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

Start date: June 30, 2018
Phase: Phase 2
Study type: Interventional

A Therapeutic Exploratory Clinical Study to evaluate the efficacy and safety of DA-8010 in Patients with Overactive Bladder and to determine the optimal dose of DA-8010

NCT ID: NCT03565458 Active, not recruiting - Clinical trials for Type 2 Diabetes Mellitus

Gemigliptin, Dapagliflozin, Empagliflozin DDI Study

Start date: April 5, 2018
Phase: Phase 1
Study type: Interventional

gemigliptin,SGLT-2i DDI study

NCT ID: NCT03565432 Enrolling by invitation - Ulcerative Colitis Clinical Trials

Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases

Start date: March 9, 2018
Phase:
Study type: Observational

Inflammatory bowel diseases (IBD) is a chronic inflammatory condition of the gastrointestinal tract that significantly affects quality of life of patients. Several studies have reported that the loss of work productivity is significantly higher than that of the general population due to disease-related symptoms and various factors in patients with inflammatory bowel disease in Western countries, but there is few data in Korea. Therefore, this study is to assess the effect of disease on sick leave, work disability and health related quality of life in Korean patients with inflammatory bowel disease by using validated questionnaires.

NCT ID: NCT03565419 Not yet recruiting - Ultrasonography Clinical Trials

Use of Smart Glasses for Ultrasound Guided Peripheral Venous Access

Start date: June 20, 2018
Phase: N/A
Study type: Interventional

Investigators aimed to explore the feasibility of smart glasses connected to a wireless ultrasound transducer for the peripheral venous access. Residents who have basic skills of ultrasound guided procedure participate in the simulation. Each participant plays the following two roles for ultrasound guided peripheral venous access; ultrasound guided peripheral venous access with and without wearing smart glasses. The order of performing two roles is determined by a randomized process and the gap between two roles are five days. The primary outcome is the time of successful blood aspiration, and secondary outcomes are first time success rate, the number of skin puncture, the number of needle redirection, the number of head movement, and subjective difficulty.

NCT ID: NCT03564405 Completed - Clinical trials for Hepatocellular Carcinoma Non-resectable

Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma

Start date: December 5, 2016
Phase: N/A
Study type: Interventional

Pilot Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

NCT ID: NCT03563716 Recruiting - Clinical trials for Non-small Cell Lung Cancer

A Study of MTIG7192A in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Start date: June 30, 2018
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and efficacy of MTIG7192A plus Atezolizumab compared with placebo plus atezolizumab in chemotherapy-naive patients with locally advanced unresectable or metastatic PD-L1-selected non-small cell lung cancer (NSCLC), excluding patients with a sensitizing EGFR mutation or ALK translocation.

NCT ID: NCT03562533 Recruiting - Ovarian Carcinoma Clinical Trials

Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

Start date: May 17, 2018
Phase:
Study type: Observational

This retrospective multicenter study aimed to evaluate the effectiveness of pegylated liposomal doxorubicin (PLD) with carboplatin (CD) compared with carboplatin and paclitaxel (CP) in patients who had disease progression longer than 6 months after first-line platinum+taxane chemotherapy for ovarian cancer in real world clinical practice.

NCT ID: NCT03561935 Recruiting - Clinical trials for Premature Ventricular Complex

Beta-blocker vs. Ic Antiarrhythmic Drug for PVC

Start date: June 2015
Phase: N/A
Study type: Interventional

The standard medical therapy of idiopathic premature ventricular complex consists of beta blocker and Ic antiarrhythmic agent. However, the difference in the efficacy of two drugs has not been well investigated. This prospective randomized study aimed to compare the efficacy of beta-blocker and Ic antiarrhythmic agent in the treatment of symptomatic patients with idiopathic premature ventricular complex.

NCT ID: NCT03561831 Recruiting - Clinical trials for Endoplasmic Reticulum Stress

Effect of Anaesthesia on ER Stress in Cancer Patients

Start date: November 2, 2017
Phase: N/A
Study type: Interventional

Investigate the change in endoplasmic reticulum stress after cancer surgery according to different anaesthetics including propofol and sevoflurane.

NCT ID: NCT03561779 Recruiting - Clinical trials for Osteoarthritis, Knee

Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee

Start date: May 1, 2018
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, active-controlled, multi-center, phase 3 study to evaluate the safety and efficacy of intraarticular hyaluronic acid(YYD302) for osteoarthritis of the knee after 12 weeks of treatment and retreatment